Description of Tolerability of LCZ696 (Sacubitril / Valsartan) in Heart Failure With Reduced Ejection Fraction (HFrEF) Treated in Real Life Setting

NCT02690974 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

302

Enrollment

INDUSTRY

Sponsor class

Conditions

Hearth Failure With Reduced Ejection Fraction (HFrEF)

Interventions

DRUG: LCZ696 (sacubitril/valsartan)

Sponsor

Novartis Pharmaceuticals